Company / Current Assets
Innoviva, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$727.5M
FY2025
5-year range
$313.7M / $727.5M
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#78 of 213
Health Care
What the data says
At $728M, Innoviva, Inc.'s current assets ranks #78 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $198M in FY2016 to $728M in FY2025.
Based on SEC 10-K filings.
$728M in FY2025 with a 5-year CAGR of +16.3%.
Improved from $344M to $728M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Sector benchmark
#78 of 213 in Health CareTop 37% of 213This company $727.5M Sector average $2.5B
▼
-71.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.3%, indicating consistent growth.
- In FY2025, current assets increased 31.2% year-over-year.
- Ranks #78 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $727.5M | +31.2% |
| FY2024 | $554.3M | +61.0% |
| FY2023 | $344.2M | -22.4% |
| FY2022 | $443.5M | +41.4% |
| FY2021 | $313.7M | -8.3% |
| FY2020 | $342.1M | -20.7% |
| FY2019 | $431.2M | +116.7% |
| FY2018 | $199.0M | -0.7% |
| FY2017 | $200.4M | +1.2% |
| FY2016 | $198.0M | -7.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026